Rita Ryan to Administration, Inhalation
This is a "connection" page, showing publications Rita Ryan has written about Administration, Inhalation.
Connection Strength
0.315
-
Respiratory Medications in Infants <29?Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium. J Pediatr. 2019 05; 208:148-155.e3.
Score: 0.154
-
Transforming growth factor alpha (TGF(alpha)) is increased during hyperoxia and fibrosis. Exp Lung Res. 2002 Jul-Aug; 28(5):361-72.
Score: 0.048
-
The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age. J Pediatr. 2017 04; 183:19-25.e2.
Score: 0.033
-
Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide. J Pediatr. 2016 Jan; 168:23-29.e4.
Score: 0.030
-
Inhaled nitric oxide increases urinary nitric oxide metabolites and cyclic guanosine monophosphate in premature infants: relationship to pulmonary outcome. Am J Perinatol. 2015 Feb; 32(3):225-32.
Score: 0.028
-
Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension. J Appl Physiol (1985). 2010 Sep; 109(3):677-84.
Score: 0.021